TP53 and B-cell chronic lymphocytic leukemia: More molecular and cytogenetic markers were included in the current scoring system, such as CLL International Prognosis Index (CLL-IPI) [2], which included TP53 gene mutation/deletion, IGHV mutation status, serum beta2 microglobulin, clinical stage and age.